Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein

Oral Surgery, Oral Medicine, Oral Pathology

Volumn 78, Issue 1, 1994, Pages 74-80

  Barnes, Leon ^a   Rao, Uma ^a   Contis, Lydia ^a   Krause, John ^b   Schwartz, Ann ^a   Scalamogna, Philip ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR; GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR; RECEPTOR, ERBB 2;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHEMISTRY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; PAROTID GLAND TUMOR; SALIVARY GLAND TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CATHEPSIN D; FEMALE; HUMAN; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGE; ONCOGENE PROTEINS, VIRAL; PAROTID NEOPLASMS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SUBMANDIBULAR GLAND NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0028471476     PISSN: 00304220     EISSN: None     Source Type: Journal    
DOI: 10.1016/0030-4220(94)90120-1     Document Type: Article

References (40)

1. Salivary duct carcinoma: Part I. a clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature
2. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin
3. Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck
4. Salivary duct adenocarcinoma
5. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques a comparison between ABC and unlabeled antibody (PAP) procedures
6. Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma
7. Hormonal therapy
8. Estrogen receptors in normal salivary gland and salivary gland carcinoma
9. High grade salivary duct carcinoma [Abstract]
10. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies
11. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphologic data
12. Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors
13. Immunohistochemistry of estrogen receptor protein in paraffin sections effects of enzymatic pretreatment and cobalt chloride intensification
14. Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer
15. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors
16. Immunocytochemical analysis of estrogen receptors in human breast carcinomas: evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevances
17. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer
18. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies: histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival
19. Quantitation of estrogen and progesterone receptors by immunocytochemical and image analysis
20. Improvement of the quantitation of estrogen and progesterone receptors in paraffin-embedded tumors by image analysis
21. Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer?
22. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer
23. Immunostaining of estrogen receptor in paraffin sections of breast carcinomas using monoclonal antibody D75P3y: effects of fixation
24. Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry: no correlation with survival at 5 years
25. Estrogen-induced lysosomal proteases secreted by cancer cells a role in … carcinogenesis?
26. Cathepsin D in breast cancer
27. Cathepsin D and prognosis in breast cancer
28. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer: an immunohistochemical study
29. Localization of the erb-2 gene on normal and rearranged chromosomes 17 to bands of q 12–21.32
30. Immunohistochemical study on overexpression of C-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients
31. Pathologic findings from the National Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer
32. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene
33. Follow-up study of HER-2/neu amplification in primary breast cancer
34. How to use prognostic factors in axillary node-negative breast cancer patients
35. Significance of c-erbB-2 amplication and DNA aneuploidy: analysis of 78 patients with node-negative breast cancer
36. Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin embedded tissue in early breast cancer; respective follow-up study of 245 stage I and II cases
37. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness
38. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study